Journal of Clinical Immunology

, Volume 25, Issue 6, pp 551–572

Human Dendritic Cell Subsets for Vaccination

  • Peter Dubsky
  • Hideki Ueno
  • Bernard Piqueras
  • John Connolly
  • Jacques Banchereau
  • A. Karolina Palucka


TProtective immunity results from the interplay of antigen (Ag)-nonspecific innate immunity and Ag-specific adaptive immunity. The cells and molecules of the innate system employ non-clonal recognition pathways such as lectins and TLRs. B and T lymphocytes of the adaptive immune system employ clonal receptors recognizing Ag or peptides in a highly specific manner. An essential link between innate and adaptive immunity is provided by dendritic cells (DCs). As a component of the innate immunc system, DC organize and transfer information from the outside world to the cells of the adaptive immune system. DC can induce such contrasting states as active immune responsiveness or immunological tolerance. Recent years have brought a wealth of information regarding DC biology and pathophysiology that shows the complexity of this cell system. Thus, presentation of antigen by immature (non-activated) DCs leads to tolerance, whereas mature, antigen-loaded DCs are geared towards the launching of antigen-specific immunity. Furthermore, DCs are composed of multiple subsets with distinct functions at the interface of the innate and adaptive immunity. Our increased understanding of DC pathophysiologywill permit their rational manipulation for therapy such as vaccination to improve immunity.

Key Words

Dendritic cell pathogens vaccination T cell immunity subsets 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 272:50, 1996PubMedGoogle Scholar
  2. 2.
    Medzhitov R, Janeway CA, Jr: Innate immunity: The virtues of a nonclonal system of recognition. Cell 91:295, 1997PubMedCrossRefGoogle Scholar
  3. 3.
    Palucka K, Banchereau J: How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr Opin Immunol 14:420, 2002PubMedCrossRefGoogle Scholar
  4. 4.
    Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271, 1991PubMedCrossRefGoogle Scholar
  5. 5.
    Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245, 1998PubMedCrossRefGoogle Scholar
  6. 6.
    Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu Y, Pulendran B, Palucka K: Immunobiology of dendritic cells. Ann Rev Immunol 18:767, 2000CrossRefGoogle Scholar
  7. 7.
    Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151, 2002PubMedCrossRefGoogle Scholar
  8. 8.
    Albert ML, Sauter B, Bhardwaj N: Dendritic cells acquire antigen from apoptotic cells and induce class I- restricted CTLs. Nature 392:86, 1998PubMedCrossRefGoogle Scholar
  9. 9.
    Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P, Silverstein RL, Bhardwaj N: Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188:1359, 1998PubMedCrossRefGoogle Scholar
  10. 10.
    Heath WR, Carbone FR: Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 19:47, 2001PubMedCrossRefGoogle Scholar
  11. 11.
    Finkelman FD, Lees A, Birnbaum R, Gause WC, Morris SC: Dendritic cells can present antigen in vivo in a tolerogenic or immunogenic fashion. J Immunol 157:1406, 1996PubMedGoogle Scholar
  12. 12.
    Pulendran B, Palucka K, Banchereau J: Sensing pathogens and tuning immune responses. Science 293:253, 2001PubMedCrossRefGoogle Scholar
  13. 13.
    Shortman K, Liu YJ: Mouse and human dendritic cell subtypes. Nat Rev Immunol 2:151, 2002PubMedCrossRefGoogle Scholar
  14. 14.
    Engering AJ, Cella M, Fluitsma D, Brockhaus M, Hoefsmit EC, Lanzavecchia A, Pieters J: The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Eur J Immunol 27:2417, 1997PubMedGoogle Scholar
  15. 15.
    Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC: The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151, 1995PubMedCrossRefGoogle Scholar
  16. 16.
    Mommaas AM, Mulder AA, Jordens R, Out C, Tan MC, Cresswell P, Kluin PM, Koning F: Human epidermal Langerhans cells lack functional mannose receptors and a fully developed endosomal/lysosomal compartment for loading of HLA class II molecules. Eur J Immunol 29:571,1999.PubMedCrossRefGoogle Scholar
  17. 17.
    Sallusto F, Cella M, Danieli C, Lanzavecchia A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products [see comments]. J Exp Med 182:389, 1995PubMedCrossRefGoogle Scholar
  18. 18.
    Tan MC, Mommaas AM, Drijfhout JW, Jordens R, Onderwater JJ, Verwoerd D, Mulder AA, van der Heiden AN, Scheidegger D, Oomen LC, Ottenhoff TH, Tulp A, Neefjes JJ, Koning F: Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur J Immunol 27:2426, 1997PubMedGoogle Scholar
  19. 19.
    Reise Sousa C, Stahl PD, Austyn JM: Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 178:509, 1993Google Scholar
  20. 20.
    Figdor CG, van Kooyk Y, Adema GJ: C-type lectin receptors on dendritic cells and Langerhans cells. Nat Rev Immunol 2:77, 2002PubMedGoogle Scholar
  21. 21.
    Cambi A, Koopman M, Figdor CG: How C-type lectins detect pathogens. Cell Microbiol 7:481, 2005PubMedCrossRefGoogle Scholar
  22. 22.
    Fanger NA, Wardwell K, Shen L, Tedder TF, Guyre PM: Type I (CD64) and type II (CD32) Fc gamma receptor-mediated phagocytosis by human blood dendritic cells. J Immunol 157:541, 1996PubMedGoogle Scholar
  23. 23.
    Rubartelli A, Poggi A, Zocchi MR: The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur J Immunol 27:1893, 1997PubMedGoogle Scholar
  24. 24.
    Inaba K, Inaba M, Naito M, Steinman RM: Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 178:479, 1993PubMedCrossRefGoogle Scholar
  25. 25.
    Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C, Rescigno M, Saito T, Verbeek S, Bonnerot C, Ricciardi-Castagnoli P, Amigorena S: Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189:371, 1999PubMedCrossRefGoogle Scholar
  26. 26.
    Delneste Y, Magistrelli G, Gauchat J, Haeuw J, Aubry J, Nakamura K, Kawakami N-Honda, Goetsch L, Sawamura T, Bonnefoy J, Jeannin P: Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17:353, 2002PubMedCrossRefGoogle Scholar
  27. 27.
    Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK: Novel signal transduction pathway utilized by extracellular HSP70: Role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277:15028, 2002PubMedCrossRefGoogle Scholar
  28. 28.
    Trombetta ES, Mellman I: Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23:975, 2005PubMedCrossRefGoogle Scholar
  29. 29.
    Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, Pack M, Subklewe M, Sauter B, Sheff D, Albert M, Bhardwaj N, Mellman I, Steinman RM: Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 188:2163, 1998PubMedCrossRefGoogle Scholar
  30. 30.
    Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, Reis e Sousa C, Germain RN, Mellman I, Steinman RM: The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J Exp Med 191:927, 2000PubMedCrossRefGoogle Scholar
  31. 31.
    Turley SJ, Inaba K, Garrett WS, Ebersold M, Unternaehrer J, Steinman RM, Mellman I: Transport of peptide-MHC class II complexes in developing dendritic cells. Science 288:522, 2000PubMedCrossRefGoogle Scholar
  32. 32.
    Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES: Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307:1630, 2005PubMedCrossRefGoogle Scholar
  33. 33.
    Ting JP, Trowsdale J: Genetic control of MHC class II expression. Cell 109(Suppl):S21, 2002PubMedCrossRefGoogle Scholar
  34. 34.
    Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B: Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 16:2851, 1997PubMedCrossRefGoogle Scholar
  35. 35.
    LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W: MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat Immunol 5:899, 2004PubMedCrossRefGoogle Scholar
  36. 36.
    Carbone FR, Heath WR: The role of dendritic cell subsets in immunity to viruses. Curr Opin Immunol 15:416, 2003PubMedCrossRefGoogle Scholar
  37. 37.
    Sigal LJ, Crotty S, Andino R, Rock KL: Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen [see comments]. Nature 398:77, 1999PubMedGoogle Scholar
  38. 38.
    Norbury CC, Basta S, Donohue KB, Tscharke DC, Princiotta MF, Berglund P, Gibbs J, Bennink JR, Yewdell JW: CD8+ T cell cross-priming via transfer of proteasome substrates. Science 304:1318, 2004PubMedCrossRefGoogle Scholar
  39. 39.
    Guermonprez P, Amigorena S: Pathways for antigen cross presentation. Springer Semin Immunopathol 26:257, 2005PubMedCrossRefGoogle Scholar
  40. 40.
    Hava DL, Brigl M, van den Elzen P, Zajonc DM, Wilson IA, Brenner MB: CD1 assembly and the formation of CD1-antigen complexes. Curr Opin Immunol 17:88, 2005PubMedCrossRefGoogle Scholar
  41. 41.
    Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB: Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372:691, 1994PubMedCrossRefGoogle Scholar
  42. 42.
    Hunger RE, Sieling PA, Ochoa MT, Sugaya M, Burdick AE, Rea TH, Brennan PJ, Belisle JT, Blauvelt A, Porcelli SA, Modlin RL: Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 113:701, 2004PubMedCrossRefGoogle Scholar
  43. 43.
    Zajonc DM, Crispin MD, Bowden TA, Young DC, Cheng TY, Hu J, Costello CE, Rudd PM, Dwek RA, Miller MJ, Brenner MB, Moody DB, Wilson IA: Molecular mechanism of lipopeptide presentation by CD1a. Immunity 22:209, 2005PubMedCrossRefGoogle Scholar
  44. 44.
    Bendelac A, Rivera MN, Park SH, Roark JH: Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu Rev Immunol 15:535, 1997PubMedCrossRefGoogle Scholar
  45. 45.
    Zhou D, Mattner J, Cantu C, 3rd, Schrantz N, Yin N, Gao Y, Sagiv Y, Hudspeth K, Wu YP, Yamashita T, Teneberg S, Wang D, Proia RL, Levery SB, Savage PB, Teyton L, Bendelac A: Lysosomal glycosphingolipid recognition by NKT cells. Science 306:1786, 2004PubMedGoogle Scholar
  46. 46.
    Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, 3rd, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A: Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434:525, 2005PubMedCrossRefGoogle Scholar
  47. 47.
    Yue SC, Shaulov A, Wang R, Balk SP, Exley MA: CD1d ligation on human monocytes directly signals rapid NF-ΚB activation and production of bioactive IL-12. Proc Natl Acad Sci USA 102:11811, 2005PubMedCrossRefGoogle Scholar
  48. 48.
    Munz C, Steinman RM, Fujii S: Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity. J Exp Med 202:203, 2005PubMedCrossRefGoogle Scholar
  49. 49.
    Caux C, Vanbervliet B, Massacrier C, Ait-Yahia S, Vaure C, Chemin K, Dieu N, Mc, Vicari A: Regulation of dendritic cell recruitment by chemokines. Transplantation 73:S7, 2002PubMedGoogle Scholar
  50. 50.
    Merad M, Manz MG, Karsunky H, Wagers A, Peters W, Charo I, Weissman IL, Cyster JG, Engleman EG: Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol 3:1135, 2002PubMedCrossRefGoogle Scholar
  51. 51.
    Caux C, Ait-Yahia S, Chemin K, de Bouteiller O, Dieu MC-Nosjean, Homey B, Massacrier C, Vanbervliet B, Zlotnik A, Vicari A: Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22:345, 2000PubMedCrossRefGoogle Scholar
  52. 52.
    Sozzani S: Dendritic cell trafficking: More than just chemokines. Cytokine Growth Factor Rev, 2005Google Scholar
  53. 53.
    McWilliam AS, Nelson D, Thomas JA, Holt PG: Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 179:1331, 1994PubMedCrossRefGoogle Scholar
  54. 54.
    McWilliam AS, Napoli S, Marsh AM, Pemper FL, Nelson DJ, Pimm CL, Stumbles PA, Wells TN, Holt PG: Dendritic cells are recruited into the airway epithelium during the inflammatory response to a broad spectrum of stimuli. J Exp Med 184:2429, 1996PubMedCrossRefGoogle Scholar
  55. 55.
    McWilliam AS, Marsh AM, Holt PG: Inflammatory infiltration of the upper airway epithelium during Sendai virus infection: involvement of epithelial dendritic cells. J Virol 71:226, 1997PubMedGoogle Scholar
  56. 56.
    Gill MA, Palucka AK, Barton T, Ghaffar F, Jafri H, Banchereau J, Ramilo O: Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis 191:1105, 2005PubMedCrossRefGoogle Scholar
  57. 57.
    Kato H, Sato S, Yoneyama M, Yamamoto M, Uematsu S, Matsui K, Tsujimura T, Takeda K, Fujita T, Takeuchi O, Akira S: Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:19, 2005PubMedCrossRefGoogle Scholar
  58. 58.
    Scandella E, Men Y, Gillessen S, Forster R, Groettrup M: Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100:1354, 2002PubMedCrossRefGoogle Scholar
  59. 59.
    Luft T, Jefford M, Luetjens P, Toy T, Hochrein H, Masterman KA, Maliszewski C, Shortman K, Cebon J, Maraskovsky E: Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: Prostaglandin E(2) regulates the migratory capacity of specific DC subsets. Blood 100:1362, 2002PubMedCrossRefGoogle Scholar
  60. 60.
    Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay C, Qin S, Lanzavecchia A: Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28:2760, 1998PubMedCrossRefGoogle Scholar
  61. 61.
    Grouard G, Durand I, Filgueira L, Banchereau J, YL L: Dendritic cells capable of stimulating T cells in germinal centers. Nature 384:364, 1996PubMedCrossRefGoogle Scholar
  62. 62.
    Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ: The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 185:1101, 1997PubMedCrossRefGoogle Scholar
  63. 63.
    Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M: Plasmacytoid monocytes migrate to inflamed lymph nodes and produce high levels of type I IFN. Nat Med 5:919, 1999PubMedGoogle Scholar
  64. 64.
    Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, Ueha S, Narumi S, Morikawa S, Ezaki T, Lu B, Gerard C, Ishikawa S, Matsushima K: Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 16:915, 2004PubMedCrossRefGoogle Scholar
  65. 65.
    Kissenpfennig A, Henri S, Dubois B, Laplace C-Builhe, Perrin P, Romani N, Tripp CH, Douillard P, Leserman L, Kaiserlian D, Saeland S, Davoust J, Malissen B: Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22:643, 2005PubMedCrossRefGoogle Scholar
  66. 66.
    Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 18:217, 2000PubMedCrossRefGoogle Scholar
  67. 67.
    Cyster JG: Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 23:127, 2005PubMedCrossRefGoogle Scholar
  68. 68.
    Yopp AC, Randolph GJ, Bromberg JS: Leukotrienes, sphingolipids, and leukocyte trafficking. J Immunol 171:5, 2003PubMedGoogle Scholar
  69. 69.
    Randolph GJ, Angeli V, Swartz MA: Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5:617, 2005PubMedCrossRefGoogle Scholar
  70. 70.
    Dieu MC, Vanderbilt B, Vicari A, Bridon JM, Oldham E, Ait-Yahia S, Briere F, Zlotnik A, Lebecque S, Caux C: Selective recruitment of immature and mature dendritic cells by distinctive chemokines expressed in different anatomic sites. J Exp Med 188:373, 1998PubMedCrossRefGoogle Scholar
  71. 71.
    Vanbervliet B, Bendriss-Vermare N, Massacrier C, Homey B, de Bouteiller O, Briere F, Trinchieri G, Caux C: The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-)/CXCL12. J Exp Med 198:823, 2003PubMedCrossRefGoogle Scholar
  72. 72.
    Randolph GJ: Dendritic cell migration to lymph nodes: Cytokines, chemokines, and lipid mediators. Semin Immunol 13:267, 2001PubMedCrossRefGoogle Scholar
  73. 73.
    Weninger W, von UH Andrian: Chemokine regulation of naive T cell traffic in health and disease. Semin Immunol 15:257, 2003PubMedCrossRefGoogle Scholar
  74. 74.
    Penna G, Vulcano M, Sozzani S, Adorini L: Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. Hum Immunol 63:1164, 2002PubMedCrossRefGoogle Scholar
  75. 75.
    Luster AD: The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 14:129, 2002PubMedCrossRefGoogle Scholar
  76. 76.
    Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C: Regulation of dendritic cell trafficking: A process that involves the participation of selective chemokines. J Leukoc Biol 66:252, 1999PubMedGoogle Scholar
  77. 77.
    Allavena P, Sica A, Vecchi A, Locati M, Sozzani S, Mantovani A: The chemokine receptor switch paradigm and dendritic cell migration: Its significance in tumor tissues. Immunol Rev 177:141, 2000PubMedCrossRefGoogle Scholar
  78. 78.
    Cyster JG: Chemokines and cell migration in secondary lymphoid organs. Science 286:2098, 1999PubMedCrossRefGoogle Scholar
  79. 79.
    Tang HL, Cyster JG: Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells. Science 284:819, 1999PubMedCrossRefGoogle Scholar
  80. 80.
    Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10, 1997PubMedCrossRefGoogle Scholar
  81. 81.
    Schaerli P, Willimann K, Lang AB, Lipp M, Loetscher P, Moser B: CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med 192:1553, 2000PubMedCrossRefGoogle Scholar
  82. 82.
    Ansel KM, Ngo VN, Hyman PL, Luther SA, Forster R, Sedgwick JD, Browning JL, Lipp M, Cyster JG: A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309, 2000PubMedGoogle Scholar
  83. 83.
    Grouard G, Durand I, Filgueira L, Banchereau J, Liu YJ: Dendritic cells capable of stimulating T cells in germinal centres. Nature 384:364, 1996PubMedCrossRefGoogle Scholar
  84. 84.
    Ngo VN, Tang HL, Cyster JG: Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J Exp Med 188:181, 1998PubMedCrossRefGoogle Scholar
  85. 85.
    Katou F, Ohtani H, Nakayama T, Nagura H, Yoshie O, Motegi K: Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin. J Pathol 199:98, 2003PubMedCrossRefGoogle Scholar
  86. 86.
    Caux C, Massacrier C, Vanbervliet B, Dubois B, Van Kooten C, Durand I, Banchereau J: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180:1263, 1994PubMedGoogle Scholar
  87. 87.
    Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH: Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27:3135, 1997PubMedGoogle Scholar
  88. 88.
    Mailliard RB, Wankowicz-Kalinska A, Cai Q, Wesa A, Hilkens CM, Kapsenberg ML, Kirkwood JM, Storkus WJ, Kalinski P: Alpha-type-1 polarized dendritic cells: A novel immunization tool with optimized CTL-inducing activity. Cancer Res 64:5934, 2004PubMedCrossRefGoogle Scholar
  89. 89.
    Klechevsky E, Kato H, Sponaas AM: Dendritic cells star in Vancouver. J Exp Med 202:5, 2005PubMedCrossRefGoogle Scholar
  90. 90.
    Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ: Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194:863, 2001PubMedCrossRefGoogle Scholar
  91. 91.
    Boonstra A, Asselin C-Paturel, Gilliet M, Crain C, Trinchieri G, Liu YJ, O'Garra A: Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 197:101, 2003PubMedCrossRefGoogle Scholar
  92. 92.
    Colonna M: Alerting dendritic cells to pathogens: The importance of Toll-like receptor signaling of stromal cells. Proc Natl Acad Sci U S A 101:16083, 2004PubMedCrossRefGoogle Scholar
  93. 93.
    Watts TH: TNF'TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23:23, 2005PubMedCrossRefGoogle Scholar
  94. 94.
    Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, Zimmermann VS, Davoust J, Ricciardi-Castagnoli P: Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 185:317, 1997PubMedCrossRefGoogle Scholar
  95. 95.
    de Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, Ait-Yahia S, Patel S, Mattei MG, Banchereau J, Zurawski S, Davoust J, Caux C, Lebecque S: A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9:325, 1998PubMedGoogle Scholar
  96. 96.
    Reis e Sousa C: Dendritic cells as sensors of infection. Immunity 14:495, 2001PubMedGoogle Scholar
  97. 97.
    Pasare C, Medzhitov R: Toll-dependent control mechanisms of CD4 T cell activation. Immunity 21:733, 2004PubMedCrossRefGoogle Scholar
  98. 98.
    Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM: Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 9:1484, 2003PubMedCrossRefGoogle Scholar
  99. 99.
    Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A: Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 6:769, 2005PubMedCrossRefGoogle Scholar
  100. 100.
    Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA: Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117:515, 2004PubMedCrossRefGoogle Scholar
  101. 101.
    Rogers NC, Slack EC, Edwards AD, Nolte MA, Schulz O, Schweighoffer E, Williams DL, Gordon S, Tybulewicz VL, Brown GD, Reis ESC: Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22:507, 2005PubMedGoogle Scholar
  102. 102.
    Itano AA, McSorley SJ, Reinhardt RL, Ehst BD, Ingulli E, Rudensky AY, Jenkins MK: Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19:47, 2003PubMedCrossRefGoogle Scholar
  103. 103.
    Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosemblatt M, Von UH Andrian: Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424:88, 2003PubMedCrossRefGoogle Scholar
  104. 104.
    Mullins DW, Sheasley SL, Ream RM, Bullock TNJ, Fu YX, Engelhard VH: Route of immunization with peptide-pulsed dendritic cells controls the distribution of memory and efefctor T cells in lymphoid tissues and determines the pattern of regional tumor control. J Exp Med 198:1, 2003CrossRefGoogle Scholar
  105. 105.
    MartIn-Fontecha A, Sebastiani S, Hopken UE, Uguccioni M, Lipp M, Lanzavecchia A, Sallusto F: Regulation of dendritic cell migration to the draining lymph node: Impact on T lymphocyte traffic and priming. J Exp Med 198:615, 2003PubMedCrossRefGoogle Scholar
  106. 106.
    Yoneyama H, Matsuno K, Toda E, Nishiwaki T, Matsuo N, Nakano A, Narumi S, Lu B, Gerard C, Ishikawa S, Matsushima K: Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 202:425, 2005PubMedCrossRefGoogle Scholar
  107. 107.
    Huang AY, Qi H, Germain RN: Illuminating the landscape of in vivo immunity: insights from dynamic in situ imaging of secondary lymphoid tissues. Immunity 21:331, 2004PubMedGoogle Scholar
  108. 108.
    Lindquist RL, Shakhar G, Dudziak D, Wardemann H, Eisenreich T, Dustin ML, Nussenzweig MC: Visualizing dendritic cell networks in vivo. Nat Immunol 5:1243, 2004PubMedCrossRefGoogle Scholar
  109. 109.
    Steinman RM, Hawiger D, Nussenzweig MC: Tolerogenic dendritic cells. Annu Rev Immunol 21:685, 2003PubMedCrossRefGoogle Scholar
  110. 110.
    Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM: Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 196:1627, 2002PubMedCrossRefGoogle Scholar
  111. 111.
    Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, Brimnes MK, Moltedo B, Moran TM, Steinman RM: In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 199:815, 2004PubMedCrossRefGoogle Scholar
  112. 112.
    Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, Inaba K, Steinman RM: Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198:235, 2003PubMedCrossRefGoogle Scholar
  113. 113.
    Sallusto F, Lanzavecchia A: Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med 189:611, 1999PubMedCrossRefGoogle Scholar
  114. 114.
    Moser M: Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity 19:5, 2003PubMedCrossRefGoogle Scholar
  115. 115.
    Walker LS, Abbas AK: The enemy within: Keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2:11, 2002PubMedCrossRefGoogle Scholar
  116. 116.
    Chang CC, Ciubotariu R, Manavalan JS, Yuan J, Colovai AI, Piazza F, Lederman S, Colonna M, Cortesini R, Dalla-Favera R, Suciu-Foca N: Tolerization of dendritic cells by T(S) cells: The crucial role of inhibitory receptors ILT3 and ILT4. Nat Immunol 3:237, 2002PubMedCrossRefGoogle Scholar
  117. 117.
    Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J: Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167:5067, 2001PubMedGoogle Scholar
  118. 118.
    Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, Koh A, Maliszewski C, Akira S, Pulendran B: A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172:4733, 2004PubMedGoogle Scholar
  119. 119.
    O'Garra A, Vieira PL, Vieira V, Goldfeld AE: IL-10-producing and naturally occurring CD4+ Tregs: Limiting collateral damage. J Clin Invest 114:1372, 2004PubMedCrossRefGoogle Scholar
  120. 120.
    Robinson DS, Larche M, Durham SR: Tregs and allergic disease. J Clin Invest 114:1389, 2004PubMedCrossRefGoogle Scholar
  121. 121.
    Walsh PT, Taylor DK, Turka LA: Tregs and transplantation tolerance. J Clin Invest 114:1398, 2004PubMedCrossRefGoogle Scholar
  122. 122.
    Apostolou I, Sarukhan A, Klein L, von Boehmer H: Origin of regulatory T cells with known specificity for antigen. Nat Immunol 3:756, 2002PubMedGoogle Scholar
  123. 123.
    Jordan MS, Boesteanu A, Reed AJ, Petrone AL, Holenbeck AE, Lerman MA, Naji A, Caton AJ: Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2:301, 2001PubMedCrossRefGoogle Scholar
  124. 124.
    Bensinger SJ, Bandeira A, Jordan MS, Caton AJ, Laufer TM: Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J Exp Med 194:427, 2001PubMedCrossRefGoogle Scholar
  125. 125.
    Mason D, Powrie F: Control of immune pathology by regulatory T cells. Curr Opin Immunol 10:649, 1998PubMedCrossRefGoogle Scholar
  126. 126.
    Groux HA, O'Garra M, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737, 1997PubMedGoogle Scholar
  127. 127.
    Sundstedt A, O'Neill EJ, Nicolson KS, Wraith DC: Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J Immunol 170:1240, 2003PubMedGoogle Scholar
  128. 128.
    Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK: Type 1 T regulatory cells. Immunol Rev 182:68, 2001PubMedCrossRefGoogle Scholar
  129. 129.
    Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 98:70, 1996PubMedGoogle Scholar
  130. 130.
    Weiner HL: Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182:207, 2001PubMedCrossRefGoogle Scholar
  131. 131.
    Jonuleit H. Schmitt E, Schuler G, Knop J, Enk AH: Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells (In process citation). J Exp Med 192:1213, 2000PubMedCrossRefGoogle Scholar
  132. 132.
    Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H: Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18:605, 2003PubMedCrossRefGoogle Scholar
  133. 133.
    Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N: Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193:233, 2001PubMedCrossRefGoogle Scholar
  134. 134.
    Akbari O, DeKruyff RH, Umetsu DT: Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2:725, 2001PubMedCrossRefGoogle Scholar
  135. 135.
    Homann D, Jahreis A, Wolfe T, Hughes A, Coon B, van Stipdonk MJ, Prilliman KR, Schoenberger SP, von Herrath MG: CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells. Immunity 16:403, 2002PubMedCrossRefGoogle Scholar
  136. 136.
    Maldonado-Lopez R, De Smedt T, Michel P, Godfroid J, Pajak B, Heirman C, Thielemans K, Leo O, Urbain J, Moser M: CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med 189:587, 1999PubMedCrossRefGoogle Scholar
  137. 137.
    Pulendran B, Smith JL, Caspary G, Brasel K, Pettit D, Maraskovsky E, Maliszewski CR: Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc Natl Acad Sci U S A 96:1036, 1999PubMedCrossRefGoogle Scholar
  138. 138.
    Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, Liu YJ: Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183, 1999PubMedCrossRefGoogle Scholar
  139. 139.
    Gilliet M, Liu YJ: Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195:695, 2002PubMedGoogle Scholar
  140. 140.
    Gilliet M, Liu YJ: Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum Immunol 63:1149, 2002PubMedCrossRefGoogle Scholar
  141. 141.
    Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693, 1992PubMedCrossRefGoogle Scholar
  142. 142.
    Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J: GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 360:258, 1992PubMedCrossRefGoogle Scholar
  143. 143.
    Romani N, Gruner S, Brang D, Kampgen E, Lenz A, Trockenbacher B, Konwalinka G, Fritsch PO, Steinman RM, Schuler G: Proliferating dendritic cell progenitors in human blood. J Exp Med 180:83, 1994PubMedCrossRefGoogle Scholar
  144. 144.
    Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109, 1994PubMedCrossRefGoogle Scholar
  145. 145.
    Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, Yoneda K, Imamura S, Schmitt D, Banchereau J: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med 184:695, 1996PubMedCrossRefGoogle Scholar
  146. 146.
    Liu YJ: IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275, 2005PubMedCrossRefGoogle Scholar
  147. 147.
    Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, Ho S, Antonenko S, Liu YJ: The nature of the principal type 1 interferon-producing cells in human blood [In process citation]. Science 284:1835, 1999PubMedCrossRefGoogle Scholar
  148. 148.
    Asselin-Paturel C, Trinchieri G: Production of type I interferons: Plasmacytoid dendritic cells and beyond. J Exp Med 202:461, 2005PubMedCrossRefGoogle Scholar
  149. 149.
    Chicha L, Jarrossay D, Manz MG: Clonal type I interferon-producing and dendritic cell precursors are contained in both human lymphoid and myeloid progenitor populations. J Exp Med 200:1519, 2004PubMedCrossRefGoogle Scholar
  150. 150.
    D'Amico A, Wu L: The early progenitors of mouse dendritic cells and plasmacytoid predendritic cells are within the bone marrow hemopoietic precursors expressing Flt3. J Exp Med 198:293, 2003PubMedCrossRefGoogle Scholar
  151. 151.
    Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG: Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med 198:305, 2003PubMedCrossRefGoogle Scholar
  152. 152.
    McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, Maliszewski CR, Lynch DH, Smith J, Pulendran B, Roux ER, Teepe M, Lyman SD, Peschon JJ: Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 95:3489, 2000PubMedGoogle Scholar
  153. 153.
    Pulendran B, Lingappa J, Kennedy MK, Smith J, Teepe M, Rudensky A, Maliszewski CR, Maraskovsky E: Developmental pathways of dendritic cells in vivo: Distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice. J Immunol 159:2222, 1997PubMedGoogle Scholar
  154. 154.
    Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, McKenna HJ: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J Exp Med 184:1953, 1996PubMedCrossRefGoogle Scholar
  155. 155.
    Pulendran B, Banchereau J, Burkeholder S, Kraus E, Guinet E, Chalouni C, Caron D, Maliszewski C, Davoust J, Fay J, Palucka K: Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 165:566, 2000PubMedGoogle Scholar
  156. 156.
    Maraskovsky E, Daro E, Roux E, Teepe M, Maliszewski CR, Hoek J, Caron D, Lebsack ME, McKenna HJ: in vivo generation of human dendritic cell subsets by Flt3 ligand. Blood 96:878, 2000PubMedGoogle Scholar
  157. 157.
    Blom B, Ho S, Antonenko S, Liu YJ: Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells. J Exp Med 192:1785, 2000PubMedCrossRefGoogle Scholar
  158. 158.
    Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH: Id2 and Id3 inhibit development of CD34+ stem cells into pre-DC2 but not into pre-DC1: Evidence for a lymphoid origin of pre-DC2. J Exp Med 192, 2000Google Scholar
  159. 159.
    Chen W, Antonenko S, Sederstrom JM, Liang X, Chan AS, Kanzler H, Blom B, Blazar BR, Liu YJ: Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 103:2547, 2004PubMedGoogle Scholar
  160. 160.
    Markowicz S, Engleman EG: Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest 85:955, 1990PubMedCrossRefGoogle Scholar
  161. 161.
    Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE: TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol 52:274, 1992PubMedGoogle Scholar
  162. 162.
    Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM: Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 166:1484, 1987PubMedCrossRefGoogle Scholar
  163. 163.
    LeVine AM, Reed JA, Kurak KE, Cianciolo E, Whitsett JA: GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection. J Clin Invest 103:563, 1999PubMedGoogle Scholar
  164. 164.
    Brandes M, Willimann K, Moser B: Professional antigen-presentation function by human gammadelta T Cells. Science 309:264, 2005PubMedCrossRefGoogle Scholar
  165. 165.
    Hanna J, Gonen-Gross T, Fitchett J, Rowe T, Daniels M, Arnon TI, Gazit R, Joseph A, Schjetne KW, Steinle A, Porgador A, Mevorach D, Goldman-Wohl D, Yagel S, LaBarre MJ, Buckner JH, Mandelboim O: Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest 114:1612, 2004PubMedCrossRefGoogle Scholar
  166. 166.
    Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA: Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11:753, 1999PubMedCrossRefGoogle Scholar
  167. 167.
    Chomarat P, Banchereau J, Davoust J, Palucka AK: IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 1:510, 2000PubMedCrossRefGoogle Scholar
  168. 168.
    Peters JH, Xu H, Ruppert J, Ostermeier D, Friedrichs D, Gieseler RK: Signals required for differentiating dendritic cells from human monocytes in vitro. Adv Exp Med Biol 329:275, 1993PubMedGoogle Scholar
  169. 169.
    Paquette RL, Hsu NC, Kiertscher SM, Park AN, Tran L, Roth MD, Glaspy JA: Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells. J Leukoc Biol 64:358, 1998PubMedGoogle Scholar
  170. 170.
    Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J: Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 161:1947, 1998PubMedGoogle Scholar
  171. 171.
    Santini SM, Lapenta C, Logozzi M, Parlato S, Spada M, Di Pucchio T, Belardelli F: Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice. J Exp Med 191:1777, 2000PubMedCrossRefGoogle Scholar
  172. 172.
    Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J: Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294:1540, 2001PubMedCrossRefGoogle Scholar
  173. 173.
    Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673, 2002PubMedGoogle Scholar
  174. 174.
    Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R, Liu YJ: Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol 5:426, 2004PubMedGoogle Scholar
  175. 175.
    Chomarat P, Dantin C, Bennett L, Banchereau J, Palucka AK: TNF skews monocyte differentiation from macrophages to dendritic cells. J Immunol 171:2262, 2003PubMedGoogle Scholar
  176. 176.
    Mohamadzadeh M, Berard F, Essert G, Chalouni C, Pulendran B, Davoust J, Bridges G, Palucka AK, Banchereau J: Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med 194:1013, 2001PubMedCrossRefGoogle Scholar
  177. 177.
    Pedersen AE, Gad M, Walter MR, Claesson MH: Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3). Immunol Lett 91:63, 2004PubMedCrossRefGoogle Scholar
  178. 178.
    Velten FW, Duperrier K, Bohlender J, Metharom P, Goerdt S: A gene signature of inhibitory MHC receptors identifies a BDCA3(+) subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro. Eur J Immunol 34:2800, 2004PubMedCrossRefGoogle Scholar
  179. 179.
    Beinhauer BG, McBride JM, Graf P, Pursch E, Bongers M, Rogy M, Korthauer U, de Vries JE, Aversa G, Jung T: Interleukin 10 regulates cell surface and soluble LIR-2 (CD85d) expression on dendritic cells resulting in T cell hyporesponsiveness in vitro. Eur J Immunol 34:74, 2004PubMedCrossRefGoogle Scholar
  180. 180.
    Banchereau J, Pascual V, Palucka AK: Autoimmunity through cytokine-induced dendritic cell activation. Immunity 20:539, 2004PubMedCrossRefGoogle Scholar
  181. 181.
    Palucka AK, Blanck JP, Bennett L, Pascual V, Banchereau J: Cross-regulation of TNF and IFN-Α in autoimmune diseases. Proc Natl Acad Sci USA 102:3372, 2005PubMedCrossRefGoogle Scholar
  182. 182.
    Caux C, Massacrier C, Vanbervliet C, Dubois B, Durand I, Cella M, Lanzavecchia A, Banchereau J: CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor alpha: II. Functional analysis. Blood 90:1458, 1997PubMedGoogle Scholar
  183. 183.
    Seifert U, Maranon C, Shmueli A, Desoutter JF, Wesoloski L, Janek K, Henklein P, Diescher S, Andrieu M, de la Salle H, Weinschenk T, Schild H, Laderach D, Galy A, Haas G, Kloetzel PM, Reiss Y, Hosmalin A: An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat Immunol 4:375, 2003PubMedCrossRefGoogle Scholar
  184. 184.
    Valladeau J, Duvert-Frances V, Pin JJ, Dezutter-Dambuyant C, Vincent C, Massacrier C, Vincent J, Yoneda K, Banchereau J, Caux C, Davoust J, Saeland S: The monoclonal antibody DCGM4 recognizes Langerin, a protein specific of Langerhans cells, and is rapidly internalized from the cell surface. Eur J Immunol 29:2695, 1999PubMedCrossRefGoogle Scholar
  185. 185.
    Valladeau J, Ravel O, Dezutter-Dambuyant C, Moore K, Kleijmeer M, Liu Y, Duvert-Frances V, Vincent C, Schmitt D, Davoust J, Caux C, Lebecques S, Saeland S: Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules. Immunity 12:71, 2000PubMedCrossRefGoogle Scholar
  186. 186.
    Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, van Kooyk Y, Figdor CG: Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses [In process citation]. Cell 100:575, 2000PubMedGoogle Scholar
  187. 187.
    Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, Figdor CG, van Kooyk Y: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [In process citation]. Cell 100:587, 2000PubMedGoogle Scholar
  188. 188.
    Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, Appelmelk B, Van Kooyk Y: Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197:7, 2003PubMedCrossRefGoogle Scholar
  189. 189.
    Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S, Buck DW, Schmitz J: BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 165:6037, 2000PubMedGoogle Scholar
  190. 190.
    Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, Facchetti F, Gunther G, Johnston I, Lanzavecchia A, Nagasaka T, Okada T, Vermi W, Winkels G, Yamamoto T, Zysk M, Yamaguchi Y, Schmitz J: BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194:1823, 2001PubMedCrossRefGoogle Scholar
  191. 191.
    Hartmann G, Weiner GJ, Krieg AM: CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci U S A 96:9305, 1999PubMedGoogle Scholar
  192. 192.
    Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, Endres S, Krieg AM, Hartmann G: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 31:2154, 2001PubMedGoogle Scholar
  193. 193.
    Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T: IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772, 2005PubMedGoogle Scholar
  194. 194.
    Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C, Taniguchi T: Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 434:1035, 2005PubMedGoogle Scholar
  195. 195.
    Kadowaki N, Antonenko S, Lau JY, Liu YJ: Natural interferon alpha/beta-producing cells link innate and adaptive immunity. J Exp Med 192:219, 2000PubMedCrossRefGoogle Scholar
  196. 196.
    Yang GX, Lian ZX, Kikuchi K, Liu YJ, Ansari AA, Ikehara S, Gershwin ME: CD4- plasmacytoid dendritic cells (pDCs) migrate in lymph nodes by CpG inoculation and represent a potent functional subset of pDCs. J Immunol 174:3197, 2005PubMedGoogle Scholar
  197. 197.
    Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J: Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 19:225, 2003PubMedCrossRefGoogle Scholar
  198. 198.
    Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Perricaudet M, Tursz T, Maraskovsky E, Zitvogel L: Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5:405, 1999PubMedGoogle Scholar
  199. 199.
    Kadowaki N, Antonenko S, Ho S, Rissoan MC, Soumelis V, Porcelli SA, Lanier LL, Liu YJ: Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells. J Exp Med 193:1221, 2001PubMedCrossRefGoogle Scholar
  200. 200.
    Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J: BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189:1747, 1999PubMedGoogle Scholar
  201. 201.
    Batten M, Groom J, Cachero TG, Qian F, Schneider P, Tschopp J, Browning JL, Mackay F: BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453, 2000PubMedCrossRefGoogle Scholar
  202. 202.
    Gross JA, Johnston J, Mudri S, Enselman R, Dillon SR, Madden K, Xu W, Parrish-Novak J, Foster D, Lofton-Day C, Moore M, Littau A, Grossman A, Haugen H, Foley K, Blumberg H, Harrison K, Kindsvogel W, Clegg CH: TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease [see comments]. Nature 404:995, 2000PubMedCrossRefGoogle Scholar
  203. 203.
    Balazs M, Martin F, Zhou T, Kearney J: Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17:341, 2002PubMedCrossRefGoogle Scholar
  204. 204.
    MacLennan I, Vinuesa C: Dendritic cells, BAFF, and APRIL. Innate players in adaptive antibody responses. Immunity 17:235, 2002PubMedCrossRefGoogle Scholar
  205. 205.
    Arpin C, Dechanet J, Van Kooten C, Merville P, Grouard G, Briere F, Banchereau J, Liu YJ: Generation of memory B cells and plasma cells in vitro. Science 268:720, 1995PubMedGoogle Scholar
  206. 206.
    Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF: Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14:461, 2001PubMedGoogle Scholar
  207. 207.
    Dubois B, Vanbervliet B, Fayette J, Massacrier C, Van Kooten C, Briere F, Banchereau J, Caux C: Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes [see comments]. J Exp Med 185:941, 1997PubMedCrossRefGoogle Scholar
  208. 208.
    Dubois B, Massacrier C, Vanbervliet B, Fayette J, Briere F, Banchereau J, Caux C: Critical role of IL-12 in dendritic cell-induced differentiation of naive B lymphocytes. J Immunol 161: 2223, 1998PubMedGoogle Scholar
  209. 209.
    Fayette J, Dubois B, Vandenabeele S, Bridon JM, Vanbervliet B, Durand I, Banchereau J, Caux C, Briere F: Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2. J Exp Med 185:1909, 1997PubMedCrossRefGoogle Scholar
  210. 210.
    Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3:822, 2002PubMedCrossRefGoogle Scholar
  211. 211.
    Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G: Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells. J Exp Med 195:327, 2002PubMedCrossRefGoogle Scholar
  212. 212.
    Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C: Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195:343, 2002PubMedCrossRefGoogle Scholar
  213. 213.
    Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, Ritter G, Schmidt R, Harris AL, Old L, Cerundolo V: NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171:5140, 2003PubMedGoogle Scholar
  214. 214.
    Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S: Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: Role of CD86 and inflammatory cytokines. J Immunol 174:252, 2005PubMedGoogle Scholar
  215. 215.
    Leslie DS, Vincent MS, Spada FM, Das H, Sugita M, Morita CT, Brenner MB: CD1-mediated gamma/delta T cell maturation of dendritic cells. J Exp Med 196:1575, 2002PubMedCrossRefGoogle Scholar
  216. 216.
    Munz C, Dao T, Ferlazzo G, de Cos MA, Goodman K, Young JW: Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood 105:266, 2005PubMedCrossRefGoogle Scholar
  217. 217.
    Adler AJ, Marsh DW, Yochum GS, Guzzo JL, Nigam A, Nelson WG, Pardoll DM: CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med 187:1555, 1998PubMedCrossRefGoogle Scholar
  218. 218.
    Sprent J, Kishimoto H: The thymus and negative selection. Immunol Rev 185:126, 2002PubMedCrossRefGoogle Scholar
  219. 219.
    Starr TK, Jameson SC, Hogquist KA: Positive and negative selection of T cells. Annu Rev Immunol 21:139, 2003PubMedCrossRefGoogle Scholar
  220. 220.
    Marrack P, Kappler J: Positive selection of thymocytes bearing alpha beta T cell receptors. Curr Opin Immunol 9:250, 1997PubMedCrossRefGoogle Scholar
  221. 221.
    Brocker T: The role of dendritic cells in T cell selection and survival. J Leukoc Biol 66:331, 1999PubMedGoogle Scholar
  222. 222.
    Fujimoto Y, Tu L, Miller AS, Bock C, Fujimoto M, Doyle C, Steeber DA, Tedder TF: CD83 expression influences CD4+ T cell development in the thymus. Cell 108:755, 2002PubMedCrossRefGoogle Scholar
  223. 223.
    Cerwenka A, Lanier LL: Natural killer cells, viruses and cancer. Nat Rev Immunol 1:41, 2001PubMedCrossRefGoogle Scholar
  224. 224.
    Cantoni C, Falco M, Pessino A, Moretta A, Moretta L, Biassoni R: P49, a putative HLA-G1 specific inhibitory NK receptor belonging to the immunoglobulin Superfamily. J Reprod Immunol 43:157, 1999PubMedGoogle Scholar
  225. 225.
    Pende D, Cantoni C, Rivera P, Vitale M, Castriconi R, Marcenaro S, Nanni M, Biassoni R, Bottino C, Moretta A, Moretta L: Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. Eur J Immunol 31:1076, 2001PubMedCrossRefGoogle Scholar
  226. 226.
    Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A: Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity. Cancer Res 62:6178, 2002PubMedGoogle Scholar
  227. 227.
    Perez-Villar JJ, Melero I, Navarro F, Carretero M, Bellon T, Llano M, Colonna M, Geraghty DE, Lopez-Botet M: The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 158:5736, 1997PubMedGoogle Scholar
  228. 228.
    Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, Jones EY, van der Merwe PA, Kumagai I, Maenaka K: Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc Natl Acad Sci U S A 100:8856, 2003PubMedCrossRefGoogle Scholar
  229. 229.
    Middleton D, Curran M, Maxwell L: Natural killer cells and their receptors. Transpl Immunol 10:147, 2002PubMedGoogle Scholar
  230. 230.
    Allan DS, McMichael AJ, Braud VM: The ILT family of leukocyte receptors. Immunobiology 202:34, 2000PubMedGoogle Scholar
  231. 231.
    Colonna M, Nakajima H, Navarro F, Lopez-Botet M: A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 66:375, 1999PubMedGoogle Scholar
  232. 232.
    Liang S, Horuzsko A: Mobilizing dendritic cells for tolerance by engagement of immune inhibitory receptors for HLA-G. Hum Immunol 64:1025, 2003PubMedCrossRefGoogle Scholar
  233. 233.
    Manavalan JS, Rossi PC, Vlad G, Piazza F, Yarilina A, Cortesini R, Mancini D, Suciu-Foca N: High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol 11:245, 2003PubMedGoogle Scholar
  234. 234.
    Ravetch JV, Bolland S: IgG Fc receptors. Annu Rev Immunol 19:275, 2001PubMedCrossRefGoogle Scholar
  235. 235.
    Ravetch JV: A full complement of receptors in immune complex diseases. J Clin Invest 110:1759, 2002PubMedCrossRefGoogle Scholar
  236. 236.
    Kalergis AM, Ravetch JV: Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells. J Exp Med 195:1653, 2002PubMedCrossRefGoogle Scholar
  237. 237.
    Dhodapkar KM, Kaufman JL, Ehlers M, Banerjee DK, Bonvini E, Koenig S, Steinman RM, Ravetch JV, Dhodapkar MV: Selective blockade of inhibitory Fcgamma receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc Natl Acad Sci U S A 102:2910, 2005PubMedGoogle Scholar
  238. 238.
    Nossal GJ: Host immunobiology and vaccine development. Lancet 350:1316, 1997PubMedCrossRefGoogle Scholar
  239. 239.
    Davis ID, Jefford M, Parente P, Cebon J: Rational approaches to human cancer immunotherapy. J Leukoc Biol 73:3, 2003PubMedCrossRefGoogle Scholar
  240. 240.
    Lu W, Arraes LC, Ferreira WT, Andrieu JM: Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med 10:1359, 2004PubMedCrossRefGoogle Scholar
  241. 241.
    Garcia F, Lejeune M, Climent N, Gil C, Alcami J, Morente V, Alos L, Ruiz A, Setoain J, Fumero E, Castro P, Lopez A, Cruceta A, Piera C, Florence E, Pereira A, Libois A, Gonzalez N, Guila M, Caballero M, Lomena F, Joseph J, Miro JM, Pumarola T, Plana M, Gatell JM, Gallart T: Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. J Infect Dis 191:1680, 2005PubMedGoogle Scholar
  242. 242.
    Banchereau J, Palucka AK: Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 5:296, 2005PubMedCrossRefGoogle Scholar
  243. 243.
    Schuler G, Schuler-Thurner B, Steinman RM: The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15:138, 2003PubMedCrossRefGoogle Scholar
  244. 244.
    Finn OJ: Cancer vaccines: between the idea and the reality. Nat Rev Immunol 3:630, 2003PubMedCrossRefGoogle Scholar
  245. 245.
    Steinman RM, Dhodapkar M: Active immunization against cancer with dendritic cells: The near future. Int J Cancer 94:459, 2001PubMedCrossRefGoogle Scholar
  246. 246.
    Gilboa E: The makings of a tumor rejection antigen. Immunity 11:263, 1999PubMedCrossRefGoogle Scholar
  247. 247.
    Wang RF, Wang X, Atwood AC, Topalian SL, Rosenberg SA: Cloning genes encoding MHC class II-restricted antigens: mutated CDC27 as a tumor antigen. Science 284:1351, 1999PubMedGoogle Scholar
  248. 248.
    Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S: Eradication of established murine tumors using a novel cell-free vaccine: Dendritic cell-derived exosomes. Nat Med 4:594, 1998PubMedCrossRefGoogle Scholar
  249. 249.
    Ribas A, Butterfield LH, Glaspy JA, Economou JS: Cancer immunotherapy using gene-modified dendritic cells. Curr Gene Ther 2:57, 2002PubMedGoogle Scholar
  250. 250.
    Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 184:465, 1996PubMedCrossRefGoogle Scholar
  251. 251.
    Fong L, Engleman EG: Dendritic cells in cancer immunotherapy. Annu Rev Immunol 18:245, 2000PubMedCrossRefGoogle Scholar
  252. 252.
    Berard F, Blanco P, Davoust J, Neidhart-Berard EM, Nouri-Shirazi M, Taquet N, Rimoldi D, Cerottini JC, Banchereau J, Palucka AK: Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med 192:1535, 2000PubMedCrossRefGoogle Scholar
  253. 253.
    Neidhardt-Berard EM, Berard F, Banchereau J, Palucka AK: Dendritic cells loaded with killed breast cancer cells induce differentiation of tumor-specific cytotoxic T lymphocytes. Breast Cancer Res 6:R322, 2004PubMedCrossRefGoogle Scholar
  254. 254.
    Banchereau J, Palucka AK, Dhodapkar M, Burkeholder S, Taquet N, Rolland A, Taquet S, Coquery S, Wittkowski KM, Bhardwaj N, Pineiro L, Steinman R, Fay J: Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine. Cancer Res 61:6451, 2001PubMedGoogle Scholar
  255. 255.
    Palucka AK, Dhodapkar MV, Paczesny S, Burkeholder S, Wittkowski KM, Steinman RM, Fay J, Banchereau J: Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma. J Immunother 26:432, 2003PubMedGoogle Scholar
  256. 256.
    Paczesny S, Banchereau J, Wittkowski KM, Saracino G, Fay J, Palucka AK: Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells. J Exp Med 199:1503, 2004PubMedCrossRefGoogle Scholar
  257. 257.
    Masopust D, Vezys V, Marzo AL, Lefrancois L: Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413, 2001PubMedCrossRefGoogle Scholar
  258. 258.
    Kaech SM, Wherry EJ, Ahmed R: Effector and memory T-cell differentiation: Implications for vaccine development. Nat Rev Immunol 2:251, 2002PubMedCrossRefGoogle Scholar
  259. 259.
    Zinkernagel RM: On natural and artificial vaccinations. Annu Rev Immunol 21:515, 2003PubMedCrossRefGoogle Scholar
  260. 260.
    Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R: Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2205, 1998PubMedCrossRefGoogle Scholar
  261. 261.
    Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R: Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77:4911, 2003PubMedCrossRefGoogle Scholar
  262. 262.
    Badovinac VP, Messingham KA, Jabbari A, Haring JS, Harty JT: Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 11:748, 2005PubMedCrossRefGoogle Scholar
  263. 263.
    Phan GQ, Wang E, Marincola FM: T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance. Expert Opin Biol Ther 1:511, 2001PubMedCrossRefGoogle Scholar
  264. 264.
    Stuge TB, Holmes SP, Saharan S, Tuettenberg A, Roederer M, Weber JS, Lee PP: Diversity and recognition efficiency of T cell responses to cancer. Plos Med 1:e28, 2004PubMedCrossRefGoogle Scholar
  265. 265.
    Lanzavecchia A, Sallusto F: Regulation of T cell immunity by dendritic cells. Cell 106:263, 2001PubMedCrossRefGoogle Scholar
  266. 266.
    Sun JC, Bevan MJ: Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300:339, 2003PubMedCrossRefGoogle Scholar
  267. 267.
    Shedlock DJ, Shen H: Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300:337, 2003PubMedCrossRefGoogle Scholar
  268. 268.
    Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP: CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature 421:852, 2003PubMedCrossRefGoogle Scholar
  269. 269.
    Northrop JK, Shen H: CD8+ T-cell memory: Only the good ones last. Curr Opin Immunol 16:451, 2004PubMedCrossRefGoogle Scholar
  270. 270.
    Kronenberg M: Toward an Understanding of NKT Cell Biology: Progress and Paradoxes. Annu Rev Immunol 23:877, 2005PubMedCrossRefGoogle Scholar
  271. 271.
    Terabe M, Matsui S, Noben-Trauth N, Chen H, Watson C, Donaldson DD, Carbone DP, Paul WE, Berzofsky JA: NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 1:515, 2000PubMedCrossRefGoogle Scholar
  272. 272.
    Steitz J, Bruck J, Lenz J, Knop J, Tuting T: Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma. Cancer Res 61:8643, 2001PubMedGoogle Scholar
  273. 273.
    Sutmuller RP, van Duivenvoorde LM, van Elsas A, Schumacher TN, Wildenberg ME, Allison JP, Toes RE, Offringa R, Melief CJ: Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 194:823, 2001PubMedCrossRefGoogle Scholar
  274. 274.
    Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH: Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res 61:4766, 2001PubMedGoogle Scholar
  275. 275.
    Viguier M, Lemaitre F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P, Ferradini L: Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173:1444, 2004PubMedGoogle Scholar
  276. 276.
    Wang HY, Lee DA, Peng G, Guo Z, Li Y, Kiniwa Y, Shevach EM, Wang RF: Tumor-specific human CD4+ regulatory T cells and their ligands: Implications for immunotherapy. Immunity 20:107Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

  • Peter Dubsky
    • 1
  • Hideki Ueno
    • 1
  • Bernard Piqueras
    • 1
  • John Connolly
    • 1
  • Jacques Banchereau
    • 1
  • A. Karolina Palucka
    • 1
    • 2
  1. 1.Baylor Institute for Immunology ResearchDallas
  2. 2.BIIRDallas

Personalised recommendations